Food and Drug Administration, April 13, 1994
Arthur Whitmore (301) 443-4177
The meeting will be from 8:30 a.m. to 5:30 p.m. on Thursday and from 8:30 a.m. to 11:30 a.m. on Friday.
Secretary of Health and Human Services Donna E. Shalala will deliver opening remarks from 8:30 to 9 a.m. on Thursday.
During the meeting the Task Force will hear from several invited speakers who will discuss AIDS drug development. An open public comment session is scheduled from 4:30 to 5:30 p.m. on Thursday.
This will be the first meeting of the Task Force since it was organized last fall to identify barriers to AIDS drug development and make recommendations to the Secretary for overcoming those barriers.
940413
FD940401
SOURCE: Food and Drug Administration (FDA).
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .